Correlation Between Acumen Pharmaceuticals and QVC

Can any of the company-specific risk be diversified away by investing in both Acumen Pharmaceuticals and QVC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acumen Pharmaceuticals and QVC into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Acumen Pharmaceuticals and QVC Group, you can compare the effects of market volatilities on Acumen Pharmaceuticals and QVC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acumen Pharmaceuticals with a short position of QVC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acumen Pharmaceuticals and QVC.

Diversification Opportunities for Acumen Pharmaceuticals and QVC

-0.29

Correlation Coefficient

Acumen Pharmaceuticals  QVC

Very good diversification

The 3 months correlation between Acumen and QVC is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Acumen Pharmaceuticals and QVC Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on QVC Group and Acumen Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acumen Pharmaceuticals are associated (or correlated) with QVC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of QVC Group has no effect on the direction of Acumen Pharmaceuticals i.e., Acumen Pharmaceuticals and QVC go up and down completely randomly.

Pair Corralation between Acumen Pharmaceuticals and QVC

Given the investment horizon of 90 days Acumen Pharmaceuticals is expected to generate 0.49 times more return on investment than QVC. However, Acumen Pharmaceuticals is 2.05 times less risky than QVC. It trades about 0.12 of its potential returns per unit of risk. QVC Group is currently generating about 0.02 per unit of risk. If you would invest  104.00  in Acumen Pharmaceuticals on May 21, 2025 and sell it today you would earn a total of  34.00  from holding Acumen Pharmaceuticals or generate 32.69% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Acumen Pharmaceuticals  vs.  QVC Group

Acumen Pharmaceuticals

Risk-Adjusted Performance

Fair

Compared to the overall equity markets, risk-adjusted returns on investments in Acumen Pharmaceuticals are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Acumen Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

QVC Group

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in QVC Group are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat conflicting technical and fundamental indicators, QVC may actually be approaching a critical reversion point that can send shares even higher in September 2025.

Pair Trading with Acumen Pharmaceuticals and QVC

The main advantage of trading using opposite Acumen Pharmaceuticals and QVC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acumen Pharmaceuticals position performs unexpectedly, QVC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in QVC will offset losses from the drop in QVC's long position.

The idea behind Acumen Pharmaceuticals and QVC Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.